FDA Inspection
Somerset Therapeutics LimitedSomerset Therapeutics Limited – FDA Inspection, Feb 19, 2020
Record Details
This FDA Inspection record concerns Somerset Therapeutics Limited, with an inspection on February 19, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 19, 2020
- Product Type
- Drugs
View Company Profile
ID · 3076e44f-4a10-4b2a-a55c-b3a3d9749b53
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1118121
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Somerset Therapeutics Limited
9| Date | Classification | Office | Project area |
|---|---|---|---|
| February 21, 2025 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 27, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 4, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 23, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 5, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Somerset Therapeutics Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.